The Wellcome Trust and the American Pharmaceutical Group came together on 2 November 2010 to tackle an important issue: intellectual property.
The conference brought together opinion formers from a diverse range of perspectives to discuss the impact of intellectual property on health in low- and middle-income countries - including public health, legal, national and pharmaceutical industry viewpoints. The day was chaired by the Director of the Wellcome Trust, Sir Mark Walport, and split into two sessions: innovation and intellectual property, the changing environment and the role of patent protection on health in low- and middle-income countries. It concluded with a panel discussion to identify key issues and suggest possible routes forward.
Visit The Wellcome Trust website  to access a selection of presentations given by speakers at the conference. Also available are short filmed interviews with a number of the speakers: Dr Jeffrey L Sturchio of the Global Health Council, Dr Timothy Wells  of Medicines for Malaria Venture, Dr Roy F Waldron of Pfizer Inc. and Dr Zafar Mirza of the World Health Organization.